Search research articles
Contact Us
Filters
Showing results (231-240 of 264) with videos related to
Page
of 27
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectory
Elyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
The Oncologist
|
October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas
Rodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancer
Elissa W P Wong, Merve Sahin, Rui Yang, et al.
The Journal of Surgical Research
|
April 6, 2013
Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases
Bin-Wei Duan, Shi-Chun Lu, Meng-Long Wang, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma
Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2023
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Hans Gelderblom, Robin L Jones, Jean-Yves Blay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
The Journal of Clinical Investigation
|
July 19, 2022
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses
Juan Yan, Yuedan Chen, Amish J Patel, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 264) with videos related to
Sort By:
Page
of 27
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectory
Elyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
The Oncologist
|
October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas
Rodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2024
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancer
Elissa W P Wong, Merve Sahin, Rui Yang, et al.
The Journal of Surgical Research
|
April 6, 2013
Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases
Bin-Wei Duan, Shi-Chun Lu, Meng-Long Wang, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma
Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2023
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Hans Gelderblom, Robin L Jones, Jean-Yves Blay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
The Journal of Clinical Investigation
|
July 19, 2022
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses
Juan Yan, Yuedan Chen, Amish J Patel, et al.
Page
of 27